LifeStance Health Group Inc [LFST] stock is trading at $4.57, up 4.58%. An important factor to consider is whether the stock is rising or falling in short-term value. The LFST shares have gain 17.18% over the last week, with a monthly amount glided 1.33%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
LifeStance Health Group Inc [NASDAQ: LFST] stock has seen the most recent analyst activity on July 25, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $8. Previously, UBS upgraded its rating to Buy on May 27, 2025, and kept the price target unchanged to $8.50. On April 08, 2025, KeyBanc Capital Markets initiated with a Overweight rating and assigned a price target of $9 on the stock. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $8 on April 03, 2025. Goldman upgraded its rating to a Buy but $10 remained the price target by the analyst firm on December 16, 2024. Barclays started tracking with a Underweight rating for this stock on January 03, 2024, and assigned it a price target of $7. In a note dated May 15, 2023, TD Cowen downgraded an Market Perform rating on this stock and boosted its target price from $8 to $9.
LifeStance Health Group Inc [LFST] stock has fluctuated between $3.74 and $8.61 over the past year. Currently, Wall Street analysts expect the stock to reach $8.5 within the next 12 months. LifeStance Health Group Inc [NASDAQ: LFST] shares were valued at $4.57 at the most recent close of the market. An investor can expect a potential return of 86.0% based on the average LFST price forecast.
Analyzing the LFST fundamentals
LifeStance Health Group Inc [NASDAQ:LFST] reported sales of 1.32B for the trailing twelve months, which represents a growth of 10.56%. Gross Profit Margin for this corporation currently stands at 0.16% with Operating Profit Margin at -0.0%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.02 and Total Capital is -0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.43 points at the first support level, and at 4.29 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.67, and for the 2nd resistance point, it is at 4.77.
Ratios To Look Out For
For context, LifeStance Health Group Inc’s Current Ratio is 1.48. On the other hand, the Quick Ratio is 1.48, and the Cash Ratio is 0.78. Considering the valuation of this stock, the price to sales ratio is 1.35, the price to book ratio is 1.21.
Transactions by insiders
Recent insider trading involved Ramtekkar Ujjwal, Chief Medical Officer, that happened on Jun 16 ’25 when 9519.0 shares were sold. Officer, Ramtekkar Ujjwal completed a deal on Jun 16 ’25 to buy 9519.0 shares. Meanwhile, Chief Medical Officer Ramtekkar Ujjwal sold 16000.0 shares on Jun 05 ’25.
